Skip to main content
. 2024 Jan 25;16(3):515. doi: 10.3390/cancers16030515

Table 5.

Second validation: CORE risk score prediction for non-relapse mortality, overall survival, and relapse.

Score Second Validation Cohort
Pat. (%) NRM OS Relapse
HR (95% CI) p (%) 2-y (%) HR (95% CI) p (%) 2-y (%) HR (95% CI) p (%) 2-y (%)
Total 0.002 <0.001 0.206
0–1 42 reference 7 reference 81 reference 25
2–4 50 3.08 (1.3–7.6) 0.014 20 3.01 (1.7–5.4) <0.001 55 1.61 (0.9–2.9) 0.11 31
≥5 8 6.49 (2.1–19.7) 0.001 43 * 5.87 (2.6–13.1) <0.001 30 * 1.95 (0.7–5.7) 0.22 31 *

For the second validation cohort, n = 205; * data only available for day 717.